Chemycal has been acquired by 3E
Learn MoreChemycal has been acquired by 3E
Learn More
Discover how Chemycal PRO helps you boosting your regulatory monitoring:
The International Agency for Research on Cancer (IARC) announced the re-review of several substances — including methyl acrylate (MA), ethyl acrylate (EA), and 2-ethylhexyl acrylate (2EHA) — as Group 2B or “possibly carcinogenic to humans.” While IARC had previously classified MA and 2EHA as Group 3 or “not classifiable as to its carcinogenicity to humans,” changes made to its Monographs Preamble in 2006 have enabled the agency to reevaluate its stance on chemicals that are not only essential components of modern everyday products, but also have a proven history of safety.
“The Group 2B classifications for MA, EA, and 2EHA are erroneous and misleading. They are based on poor science and a flawed, non-transparent process. All these substances are well studied and the evidence strongly shows they are highly unlikely to cause cancer in humans. BAMM member companies stand behind the safety of their acrylates,” said Elizabeth Hunt, Executive Director of the Basic Acrylic Monomer Manufacturers, Inc. (BAMM). “It is critical that IARC both modernize its scientific practices as well as implement policies which enhance transparency and objectivity instead of misinforming the public on substances that are deemed safe by other global health organizations. A revision of the Preamble to improve the scientific practices at IARC is necessary.”
CONTINUE READING ON www.americanchemistry.com
2013 © MyChemicalMonitoring. ALL Rights Reserved. About Us | Terms and Conditions